CEO Doug Biehn sits down with Nasdaq’s Leigh Hixon to share Octave’s vision of transforming neurodegenerative disease care through precision medicine. Watch Now

Get in Touch

Our Science

Powerful innovation to transform MS

We're committed to rigorous and ongoing evaluation.

Browse our latest publications below.

Glial Cell Injury and MRI Measures of Chronic Multiple Sclerosis Inflammation

  • Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF

Association between Serum Biomarkers Profile and real world Evidence of Disability in Multiple Sclerosis

  • Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF

Real World Considerations Regarding MRI Use in a Clinic Setting

  • Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF

Proteomic Biomarker Panel for Gauging Multiple Sclerosis Disease Activity: A Case Series from Real-World Use

  • Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF

Urinary Tract Infections in People with Multiple Sclerosis: A Real-World Administrative Claims Study

  • Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF

Blood Serum Proteome Correlates of Multiple Sclerosis Disease Progression as evaluated by Neuropsychological Test Outcomes: A 5-Year Longitudinal Study

  • Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF

Serum Biomarkers of Brain Atrophy in Multiple Sclerosis

  • Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF

Sex-Specific Brain Charts for Multiple Sclerosis

  • Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF

Substantial Variability of Neurologist Decision-Making Based on MRI Reports

  • Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF

Brain Charts for People Living with Multiple Sclerosis

  • Research Presented at the Annual ECTRIMS Meeting - October 26-28, 2022
Download PDF
1 … 4 5 6 … 9

Glial Cell Injury and MRI Measures of Chronic Multiple Sclerosis Inflammation

  • Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF

Association between Serum Biomarkers Profile and real world Evidence of Disability in Multiple Sclerosis

  • Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF

Real World Considerations Regarding MRI Use in a Clinic Setting

  • Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF

Proteomic Biomarker Panel for Gauging Multiple Sclerosis Disease Activity: A Case Series from Real-World Use

  • Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF

Urinary Tract Infections in People with Multiple Sclerosis: A Real-World Administrative Claims Study

  • Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF

Blood Serum Proteome Correlates of Multiple Sclerosis Disease Progression as evaluated by Neuropsychological Test Outcomes: A 5-Year Longitudinal Study

  • Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF

Serum Biomarkers of Brain Atrophy in Multiple Sclerosis

  • Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF

Sex-Specific Brain Charts for Multiple Sclerosis

  • Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF

Substantial Variability of Neurologist Decision-Making Based on MRI Reports

  • Research Presented at the Annual ACTRIMS Meeting - February 23-25, 2023
Download PDF

Brain Charts for People Living with Multiple Sclerosis

  • Research Presented at the Annual ECTRIMS Meeting - October 26-28, 2022
Download PDF
Load More

© 2024 Octave Bioscience, Inc | 1440 O’Brien Drive, Suite B, Menlo Park, CA 94025 

Connect with us